[Federal Register: October 16, 2002 (Volume 67, Number 200)]
[Notices]
[Page 63933-63934]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16oc02-90]
 
-----------------------------------------------------------------------
 
DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
Food and Drug Administration
 
 
Infant Formula Subcommittee of the Food Advisory Committee;
Notice of Meeting
 
AGENCY: Food and Drug Administration, HHS.
 
ACTION: Notice.
 
-----------------------------------------------------------------------
 
    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
    Name of Committee: Infant Formula Subcommittee of the Food Advisory
Committee.
    General Function of the Committee: To provide advice and
recommendations to the agency on scientific issues and principals
related to FDA's regulatory issues.
    Date and Time: The meeting will be held on November 18, 2002, from
8 a.m. to 6 p.m. and November 19, 2002, from 8 a.m. to 5 p.m.
    Location: U.S. Department of Agriculture, Animal and Plant Health
Inspection Service, Conference Center, 4700 River Rd., Riverdale, MD,
301-734-8010.
    Contact Person: Jeanne E. Latham, Center for Food Safety and
Applied Nutrition (HFS-800), Food and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740, 301-436-1756, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 10564. Please call the Information Line for
up-to-date information on this meeting.
    Agenda: The meeting's purpose is to discuss the scientific issues
and principles involved in assessing and evaluating whether a ``new''
infant formula supports normal physical growth in infants when consumed
as a sole source of nutrition. This is the second meeting of a series
of advisory committee meetings to discuss the scientific issues
involved in evaluating whether a new infant formula supports normal
physical growth.
    FDA will post information relating to this meeting on the Internet
at http://www.cfsan.fda.gov/[tilde]lrd/vidtel.html.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by November 1,
2002. Oral presentations from the public will be scheduled between
approximately 8:30 a.m. and 9:30 a.m. on November 19, 2002. Time
allotted for each presentation may be limited. Those desiring to make
formal oral presentations should notify the contact person before
November 13, 2002, and submit a brief statement of the general nature
of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Jeanne E. Latham at
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
 
 
[[Page 63934]]
 
 
    Dated: October 9, 2002.
Linda Arey Skladany,
Senior Associate Commissioner for External Relations.
[FR Doc. 02-26325 Filed 10-15-02; 8:45 am]
BILLING CODE 4160-01-S